Approx. 3 months (12 weeks and 3 days / 88 days total) on 1mg Finasteride
    8/22/2026

    From the encyclopedia
    Finasteride β†’

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Minoxidil β†’

    Vasodilator used on the scalp and, at low doses, as a tablet

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Finasteride (oral) 1mg daily 3 months
    πŸ’§ Minoxidil (topical)
    the tone is πŸ˜€ positive with improved crown density results.

    Other terms

    A 27-year-old male has been using 1mg finasteride daily for hair loss and noticed improved crown density after three months. He previously used topical minoxidil but stopped due to scalp irritation and is considering oral minoxidil or a hair transplant in the future.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Androgenetic Alopecia

      November 2015 in “Springer eBooks”
      Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

      research Female pattern hair lossβ€”An update

      12 citations , January 2020 in “Indian Dermatology Online Journal”
      This article discusses the causes, diagnosis, and treatment options for female pattern hair loss, emphasizing the role of topical minoxidil as a primary treatment, but provides no new clinical results.

      research An overview of female pattern hair loss

      2 citations , June 2011 in “Expert Review of Dermatology”
      This review discusses the characteristics and management options for female pattern hair loss, highlighting the unclear role of androgens and the psychosocial impact, and reports no new clinical results.

      research Hair aging and anti-aging

      3 citations , October 2007 in “Expert Review of Dermatology”
      This review discusses the biological and cosmetic aspects of hair aging and reports no new clinical results; it highlights current treatments and future research directions to address both aging factors.